Dr Walfridsson

Dr Walfridsson

In our PIP4K2 project there were indications that AML, acute myeloid leukemia, could be an interesting indication. We therefore started a collaboration with Dr Julian Walfridsson’s group at the Center for Hematology and Regenerative Medicine (HERM) at Karolinska Institutet. They have access to a national biobank with blood samples from patients diagnosed with any hematological disease, mainly AML.